Vitamin D receptor mRNA measured in leukocytes with the TaqMan fluorogenic detection system: effect of calcitriol administration.

BACKGROUND The aim of the present study was to investigate the interactions between the circulating concentrations of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and the mRNA concentration of its specific nuclear receptor in human leukocytes. METHODS We measured vitamin D receptor (VDR) mRNA extracted from leukocytes by use of TaqMan fluorescence analysis applied to the reverse transcription-PCR (RT-PCR) technique in 16 volunteers before and after calcitriol administration. VDR mRNA was also measured in leukocytes from calcium-stone-formers (37 hypercalciuric and 34 normocalciuric patients). The relationship between VDR mRNA concentrations and genetic VDR polymorphisms was analyzed in these patients. RESULTS Imprecision (CV) of RT-PCR was 1.3% within assay (n = 10) and 1.7% between assays (n = 4). Oral 1,25(OH)2D3 increased mean (SE) serum 1,25(OH)2D3 1.6 (0.3)-fold and VDR mRNA 1.6 (0.1)-fold 8 h after administration. The maximum VDR mRNA was reached 3.6 (1.3) h after 1,25(OH)2D3 ingestion. No differences in leukocyte VDR mRNA concentrations were found between normocalciuric and hypercalciuric stone-formers in the absence of stimulation. Finally, no association was found between VDR mRNA concentrations and genetic VDR polymorphisms in stone-formers. CONCLUSIONS The TaqMan RT-PCR assay is a rapid and accurate method to measure VDR mRNA, and leukocytes are a useful model to study VDR and 1,25(OH)2D3 interactions. In humans, VDR mRNA is increased by agonist 1,25(OH)2D3, a finding resembling previously reported results obtained in cellular and animal models.

[1]  P. Dhawan,et al.  New insights into the mechanisms of vitamin D action , 2003, Journal of cellular biochemistry.

[2]  G. Vezzoli,et al.  Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones. , 2002, Journal of nephrology.

[3]  Thomas D. Schmittgen,et al.  Real-Time Quantitative PCR , 2002 .

[4]  G. Ardissino,et al.  No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure. , 2000, Kidney international.

[5]  M. Galligan,et al.  The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. , 2000, Molecular endocrinology.

[6]  H. Pols,et al.  Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1,25‐dihydroxyvitamin D3 , 2000, Clinical endocrinology.

[7]  B. Gagnon,et al.  Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. , 1999, Journal of the American Society of Nephrology : JASN.

[8]  A. Caumo,et al.  Study of calcium metabolism in idiopathic hypercalciuria by strontium oral load test. , 1999, Clinical chemistry.

[9]  J. Yao,et al.  Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats. , 1998, The Journal of clinical investigation.

[10]  H. Yamamoto,et al.  Structural organization of the human vitamin D receptor chromosomal gene and its promoter. , 1997, Molecular endocrinology.

[11]  Y. Taketani,et al.  A Vitamin D Receptor Gene Polymorphism in the Translation Initiation Codon: Effect on Protein Activity and Relation to Bone Mineral Density in Japanese Women , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  J. Silver,et al.  Nanoliter scale PCR with TaqMan detection. , 1997, Nucleic acids research.

[13]  S. Gelmini,et al.  Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification. , 1997, Clinical chemistry.

[14]  C. Heid,et al.  A novel method for real time quantitative RT-PCR. , 1996, Genome research.

[15]  J. Zerwekh,et al.  Vitamin D receptor quantitation in human blood mononuclear cells in health and disease , 1993, Molecular and Cellular Endocrinology.

[16]  J. Hartley,et al.  Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. , 1990, Gene.

[17]  H. DeLuca,et al.  Serum calcium and vitamin D regulate 1,25-dihydroxyvitamin D3 receptor concentration in rat kidney in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Shine,et al.  Cloning and expression of full-length cDNA encoding human vitamin D receptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[20]  D. Feldman,et al.  Homologous up-regulation of the 1,25 (OH)2 vitamin D3 receptor in rats. , 1986, Biochemical and biophysical research communications.

[21]  S. Manolagas,et al.  1,25-dihydroxyvitamin D3 receptors in human leukocytes. , 1983, Science.

[22]  ScienceDirect,et al.  Joint, bone, spine , 2000 .

[23]  B. Komm,et al.  Molecular biology of the vitamin D hormone. , 1988, Recent progress in hormone research.

[24]  J. Freytag,et al.  Clinical Chemistry , 1985, Analytical chemistry.